Come and join us across the globe
Sign In

Wrap-up interview: First pass rate, best option! Cerenovus change the trajectory of stroke...

Last update on October 22, 2021

During LINNC Paris 2018, Professor Tommy Andersson presented his findings of a study using EMBOTRAP® Device Retriever during treatment of stroke yields positive rates of revascularization (ARISE II) and his thoughts on why the first pass is always the best option.

On the same subject
Come and join us across the globe